Clinical Trial Update: Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prandial inhaled insulin (Technosphere/insulin) with or without metformin, compared to two oral antidiabetic agents in type 2 diabetes;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)
• metformin (metformin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-10-16